Ginkgo Bioworks
DNA
DNA
157 hedge funds and large institutions have $214M invested in Ginkgo Bioworks in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 49 increasing their positions, 56 reducing their positions, and 180 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $312M → $214M (-$97M)
50% less funds holding
Funds holding: 312 → 157 (-155)
84% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 180
Holders
157
Holding in Top 10
2
Calls
$22M
Puts
$7.67M
Top Buyers
| 1 | +$6.68M | |
| 2 | +$6.11M | |
| 3 | +$3.89M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.58M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.92M |
Top Sellers
| 1 | -$7.97M | |
| 2 | -$7.08M | |
| 3 | -$5.22M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.31M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.78M |